Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma.
C BenceV HofmanE ChamoreyE Long-MiraS LassalleA F AlbertiniI LioliosK ZahafA PicardH MontaudiéJean-Philippe LacourThierry PasseronA A AndeaVéronique HofmanP HofmanPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)
The pretreatment combination of PD-L1 expression with the level of CD8+ TILs could better assess OS and predict therapeutic response of patients with metastatic melanoma treated by either immunotherapy or other treatment regimens.
Keyphrases